CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

CVS Health’s rehabilitation efforts to return to full strength appear to be on track after a strong fourth quarter. The ...

CVS Health beats fourth-quarter expectations and reaffirms long-term guidance as its turnaround gains momentum across key ...

CVS Health reaffirmed its guidance for full year 2026 revenue of at least $400 billion and adjusted EPS in the range of $7 to $7.20. Newman commented, "We are encouraged by the strength of our results ...

Feb 10 (Reuters) - CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped by strength in its pharmacy benefit unit and strong prescription volume at ...

CVS Health reported less than $1.8 billion profit in 2025, down 61.8% year over year, according to a Feb. 10 earnings release. Fourth-quarter net income attributable to CVS Health was $2.9 billion, up ...

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining almost 300 points on Tuesday. The Dow traded up 0.59% to 50,433.63 while the NASDAQ rose 0.04% to 23,248.03. The S&P ...

The changes come as the wider retail-pharmacy market has been upended in recent years.

For the quarter ended December 2025, CVS Health (CVS) reported revenue of $105.69 billion, up 8.2% over the same period last year. EPS came in at $1.09, compared to $1.19 in the year-ago quarter. The ...